Page last updated: 2024-11-04

sulfasalazine and Diabetes Mellitus

sulfasalazine has been researched along with Diabetes Mellitus in 2 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uutela, T1
Kautiainen, H1
Järvenpää, S1
Salomaa, S1
Hakala, M1
Häkkinen, A1
Kanda, A1
Arakawa, M1
Sasaki, Y1

Other Studies

2 other studies available for sulfasalazine and Diabetes Mellitus

ArticleYear
Patients with rheumatoid arthritis have better functional and working ability but poorer general health and higher comorbidity rates today than in the late 1990s.
    Scandinavian journal of rheumatology, 2015, Volume: 44, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Produc

2015
Anticardiolipin antibodies in Crohn's disease associated with diabetes mellitus.
    Internal medicine (Tokyo, Japan), 1996, Volume: 35, Issue:11

    Topics: Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Blood Glucose; Colitis; Crohn Disease; Diabet

1996